Join the club for FREE to access the whole archive and other member benefits.
Olaparib delays cancer growth by months, which means the increased lifespan
Key points from article :
Olaparib is the first genetically targeted drug for fighting prostate cancer.
Drug works by targeting and killing cancer cells with faulty genetic code.
Olaparib could be made available to patients in the next couple of years.
Drug is also called Lynparza and made by AstraZeneca.
Click on resource name for more details.
Independent cancer charity focused on saving lives through research, influence and information
One of the world’s most influential cancer research organizations
